Clinical studies are underway

By Michelle Barson, KeraVet Bio Staff

Our KeraVet Gel clinical study is underway and we’re anticipating results in March 2023.

Our clinical study is taking place in South Africa and is being conducted by the scientists and veterinarians at ClinVet. The purpose of the study is to determine the efficacy of KeraVet Gel when compared to no treatment at all, which is reportedly the most common standard of care for surgeries at this time.

Currently, veterinarians treat wounds (surgical and otherwise) in three ways.

No treatment at all. This approach leaves the injury site accessible to the pet. Biting and licking of the wound area can result in the need for return veterinarian visits.

Lick and bite deterrent. This typically takes the form of E-collar or bandages. In this case, the veterinarian wants to be sure the wound doesn’t worsen or become infected from licking and biting.

Lick and bite deterrent along with other treatments. These other treatments may include antibiotics, over-the-counter topical products, etc. This “kitchen sink” course of action allows a vet to manage the wound and keep the pet from aggravating it; however, this approach requires multiple products to achieve the desired outcome.

It is our goal to provide veterinarians and pet owners with a clear course of post-surgical treatment.  KeraVet Gel is designed to be the only product needed for managing post-surgical wounds, including deterring the patient from licking or biting at the impacted area. Additionally, KeraVet Gel will support positive wound outcomes by providing a moist wound bed and barrier to the elements.

Utilizing KeraVet Gel, instead of relying on one of three courses of care listed above, is expected to have many benefits for the patient including:

  • Reduced anxiety, pain and overall longevity of discomfort.
  • Less trauma resulting in less impact to the animal-human bond.
  • Decreased likelihood for reinjury and secondary issues resulting in fewer follow up appointments.